425: Strive CFO Reposts Merger Update with Semler Scientific

Sentiment:

Merger Communication


Strive's CFO reposted a communication regarding the proposed business combination with Semler Scientific, highlighting forward-looking statements and regulatory filing details.

Capital raiseStrive will issue additional shares of its Class A common stock in connection with the proposed business combination with Semler Scientific, which may cause dilution.

Summary

  • Ben Pham, Chief Financial Officer of Strive, Inc., reposted a communication on September 26, 2025, concerning the proposed business combination with Semler Scientific, Inc.
  • The communication contains forward-looking statements regarding the outlook, strategic and financial benefits, timing, and integration of the proposed transaction.
  • It emphasizes that these statements involve inherent risks and uncertainties that could cause actual results to differ materially from anticipated results.
  • Strive intends to file a Registration Statement on Form S-4 with the SEC, which will include an Information Statement/Proxy Statement/Prospectus.
  • Investors and stockholders of Semler Scientific are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus when they become available, as they will contain important information.
  • Details are provided on where to obtain these and other relevant SEC filings, including the SEC's website and the companies' respective investor relations channels.
  • Strive, Semler Scientific, and certain directors, executive officers, and employees may be deemed participants in the solicitation of proxies from Semler Scientific stockholders.
  • The communication clarifies that it does not constitute an offer to sell or a solicitation of an offer to buy any securities or a solicitation of any vote or approval.

Sentiment

Score: 5

Explanation: The filing is a standard cautionary statement regarding a proposed business combination, emphasizing risks and regulatory compliance rather than providing new positive or negative operational updates. It is neutral in tone, focusing on legal disclosure requirements.

Risks

  • The occurrence of any event, change, or circumstances that could give rise to the right of one or both companies to terminate the merger agreement.
  • The possibility that the proposed transaction does not close when expected or at all because conditions to closing are not received or satisfied on a timely basis or at all.
  • The outcome of any legal proceedings that may be instituted against Strive, Semler Scientific, or the combined company.
  • The possibility that anticipated benefits of the proposed transaction, including cost savings and strategic gains, are not realized when expected or at all.
  • Risks associated with changes in, or problems arising from, implementation of Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets.
  • General economic and market conditions, interest and exchange rates, monetary policy, and laws and regulations and their enforcement could impact anticipated benefits.
  • The possibility that the integration of the two companies may be more difficult, time-consuming, or costly than expected.
  • The possibility that the proposed transaction may be more expensive or take longer to complete than anticipated due to unexpected factors or events.
  • Diversion of management's attention from ongoing business operations and opportunities.
  • Dilution caused by Strive's issuance of additional shares of its Class A common stock in connection with the proposed transaction.
  • Potential adverse reactions of Strive's or Semler Scientific's customers or changes to business or employee relationships resulting from the announcement or completion of the proposed transaction.
  • Changes in Strive's or Semler Scientific's share price before closing.
  • Other factors, including unknown or unpredictable factors, that may affect future results of Strive, Semler Scientific, or the combined company.

Future Outlook

The future outlook centers on the successful completion and integration of the proposed business combination between Strive and Semler Scientific, with an expectation of strategic and financial benefits. However, this outlook is explicitly subject to numerous inherent risks and uncertainties, including those related to market conditions, regulatory changes, and integration challenges.

Management Comments

  • Ben Pham, Chief Financial Officer of Strive, Inc., reposted the communication on X.com, indicating management's active dissemination of information regarding the proposed business combination.

Industry Context

The mention of 'Bitcoin treasury strategies and risks associated with Bitcoin and other digital assets' suggests that at least one of the companies, or the combined entity, has exposure to or plans to engage with the digital asset space, reflecting a growing trend among some corporations to incorporate digital assets into their treasury management or strategic operations.

Stakeholder Impact

  • Shareholders of Strive may experience dilution due to the issuance of additional Class A common stock in connection with the transaction.
  • Shareholders of Semler Scientific will be asked to approve the proposed transaction.
  • Customers of both companies may have adverse reactions to the proposed transaction.
  • Employee relationships at both companies could change as a result of the proposed transaction.

Next Steps

  • Strive intends to file a Registration Statement on Form S-4 with the SEC to register Class A common stock for the proposed transaction.
  • The Registration Statement will include an Information Statement/Proxy Statement/Prospectus for Strive and Semler Scientific.
  • A definitive Information Statement/Proxy Statement/Prospectus will be sent to Semler Scientific stockholders to seek their approval of the proposed transaction.
  • Investors and stockholders are urged to read the Registration Statement and Information Statement/Proxy Statement/Prospectus, along with other relevant SEC documents, when they become available.

Key Dates

DateDescription
2024-12-31Fiscal year end for Semler Scientific's most recent annual report on Form 10-K.
2025-07-17Semler Scientific's definitive proxy statement for its 2025 Annual Meeting of Stockholders filed with the SEC.
2025-09-12Strive's current report on Form 8-K filed with the SEC.
2025-09-15Strive's current report on Form 8-K filed with the SEC.
2025-09-26Communication reposted on X.com by Ben Pham, CFO of Strive, Inc.

Recommendation

hold

This filing is a regulatory communication regarding a proposed business combination, primarily outlining forward-looking statements and associated risks. It does not contain new financial results or operational updates that would significantly alter an investment thesis at this stage. Investors should await the full Registration Statement on Form S-4 for comprehensive details before making definitive investment decisions.

Keywords

Merger, Acquisition, Business Combination, Strive Inc, Semler Scientific Inc, SEC Filing, Form 425, Forward-Looking Statements, Bitcoin Treasury, Corporate Governance, Risk Management

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.